wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35967917-6D3ADF78-829A-4AF8-BFC7-D9937475BC63
Q35967917-6D3ADF78-829A-4AF8-BFC7-D9937475BC63
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35967917-6D3ADF78-829A-4AF8-BFC7-D9937475BC63
Antibody Drug Conjugates: Nonclinical Safety Considerations.
P2860
Q35967917-6D3ADF78-829A-4AF8-BFC7-D9937475BC63
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35967917-6D3ADF78-829A-4AF8-BFC7-D9937475BC63
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f5a322d55047fc07e7a367a2456b1c84742538bc
P2860
A phase I dose escalation study with anti-CD44v6 bivatuzumab mertansine in patients with incurable squamous cell carcinoma of the head and neck or esophagus